658 related articles for article (PubMed ID: 30760569)
1. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
[TBL] [Abstract][Full Text] [Related]
2. Delimitation of the tick-borne flaviviruses. Resolving the tick-borne encephalitis virus and louping-ill virus paraphyletic taxa.
Bondaryuk AN; Andaev EI; Dzhioev YP; Zlobin VI; Tkachev SE; Kozlova IV; Bukin YS
Mol Phylogenet Evol; 2022 Apr; 169():107411. PubMed ID: 35032647
[TBL] [Abstract][Full Text] [Related]
3. Population genomics of louping ill virus provide new insights into the evolution of tick-borne flaviviruses.
Clark JJ; Gilray J; Orton RJ; Baird M; Wilkie G; Filipe ADS; Johnson N; McInnes CJ; Kohl A; Biek R
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008133. PubMed ID: 32925939
[TBL] [Abstract][Full Text] [Related]
4. Tick-borne encephalitis virus and louping-ill virus may co-circulate in Southern Norway.
Ytrehus B; Vainio K; Dudman SG; Gilray J; Willoughby K
Vector Borne Zoonotic Dis; 2013 Oct; 13(10):762-8. PubMed ID: 23808981
[TBL] [Abstract][Full Text] [Related]
5. Genomic sequence of the structural proteins of louping ill virus: comparative analysis with tick-borne encephalitis virus.
Shiu SY; Ayres MD; Gould EA
Virology; 1991 Jan; 180(1):411-5. PubMed ID: 1845834
[TBL] [Abstract][Full Text] [Related]
6. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease.
Agudelo M; Palus M; Keeffe JR; Bianchini F; Svoboda P; Salát J; Peace A; Gazumyan A; Cipolla M; Kapoor T; Guidetti F; Yao KH; Elsterová J; Teislerová D; Chrdle A; Hönig V; Oliveira T; West AP; Lee YE; Rice CM; MacDonald MR; Bjorkman PJ; Růžek D; Robbiani DF; Nussenzweig MC
J Exp Med; 2021 May; 218(5):. PubMed ID: 33831141
[TBL] [Abstract][Full Text] [Related]
7. Characterization of neutralizing monoclonal antibody against tick-borne encephalitis virus in vivo.
Matveev A; Matveev L; Stronin O; Baykov I; Emeljanova L; Khlusevich Y; Tikunova N
Vaccine; 2020 Jun; 38(27):4309-4315. PubMed ID: 32409136
[TBL] [Abstract][Full Text] [Related]
8. A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody.
Svoboda P; Haviernik J; Bednar P; Matkovic M; Cervantes Rincón T; Keeffe J; Palus M; Salat J; Agudelo M; Nussenzweig MC; Cavalli A; Robbiani DF; Ruzek D
Cell Rep; 2023 Sep; 42(9):113149. PubMed ID: 37715951
[TBL] [Abstract][Full Text] [Related]
9. Engineering of Chimeric Protein Based on E Protein Domain III of Tick- Borne Encephalitis Virus and OmpF Porin of Yersinia pseudotuberculosis.
Stenkova AM; Chopenko NS; Davydova LA; Mazeika AN; Bystritskaya EP; Portnyagina OY; Anastyuk SD; Kulbatskii DS; Lyukmanova EN; Dolgikh DA; Kostetsky EY; Sanina NM
Protein Pept Lett; 2017; 24(10):974-981. PubMed ID: 28741465
[TBL] [Abstract][Full Text] [Related]
10. Flavivirus-induced antibody cross-reactivity.
Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR
J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425
[TBL] [Abstract][Full Text] [Related]
11. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent enhancement of tick-borne encephalitis virus infectivity.
Phillpotts RJ; Stephenson JR; Porterfield JS
J Gen Virol; 1985 Aug; 66 ( Pt 8)():1831-7. PubMed ID: 2991448
[TBL] [Abstract][Full Text] [Related]
14. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody.
Füzik T; Formanová P; Růžek D; Yoshii K; Niedrig M; Plevka P
Nat Commun; 2018 Jan; 9(1):436. PubMed ID: 29382836
[TBL] [Abstract][Full Text] [Related]
15. Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick-borne encephalitis and dengue virus infections.
Roßbacher L; Malafa S; Huber K; Thaler M; Aberle SW; Aberle JH; Heinz FX; Stiasny K
J Med Virol; 2023 Nov; 95(11):e29245. PubMed ID: 38009693
[TBL] [Abstract][Full Text] [Related]
16. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
17. Exploration of binary protein-protein interactions between tick-borne flaviviruses and Ixodes ricinus.
Lemasson M; Caignard G; Unterfinger Y; Attoui H; Bell-Sakyi L; Hirchaud E; Moutailler S; Johnson N; Vitour D; Richardson J; Lacour SA
Parasit Vectors; 2021 Mar; 14(1):144. PubMed ID: 33676573
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the viral envelope.
Holoubek J; Salát J; Kotouček J; Kastl T; Vancová M; Huvarová I; Bednář P; Bednářová K; Růžek D; Renčiuk D; Eyer L
Antiviral Res; 2024 Jan; 221():105767. PubMed ID: 38040199
[TBL] [Abstract][Full Text] [Related]
19. New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E.
Matveev A; Khlusevich Y; Kozlova I; Matveev L; Emelyanova L; Tikunov A; Baykov I; Tikunova N
Viruses; 2023 May; 15(6):. PubMed ID: 37376556
[No Abstract] [Full Text] [Related]
20. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
